Warfarin versus factor Xa inhibitors in the long-term treatment of cerebral venous sinus thrombosis a single-center retrospective analysis

Warfarin versus factor Xa inhibitors in the long-term treatment of cerebral venous sinus thrombosis a single-center retrospective analysis

Long-term anticoagulation in the treatment of Cerebral Venous Sinus Thrombosis (CVST) has revolved around the use of warfarin. The relatively recent introduction of Direct Oral Anticoagulants (DOACs), such as Factor Xa inhibitors, in treating CVSTs promises to offer numerous patient benefits. We aim...

Full description

Bibliographic Details
Main Authors: Alexei Christodoulides, Bradley N. Bohnstedt
Format: Article
Language:English
Published: Elsevier 2022-09-01
Series:eNeurologicalSci
Subjects:
Cerebral venous sinus thrombosis
Warfarin
DOACs
Factor Xa inhibitors
Retrospective analysis
Online Access:http://www.sciencedirect.com/science/article/pii/S2405650222000211

Internet

http://www.sciencedirect.com/science/article/pii/S2405650222000211

Similar Items